In particular, CYP17A1 upregulation was caused by the inhibitory effect of Sp1 on DNMT3a-mediated CYP17A1 repression, and CYP17A1 induced TMZ resistance by increasing DHEA production in GBM. This evidence concerns the gene DNMT3A and glioblastoma.